Marvin Samson, Director at ANTARES PHARMA, INC. (ATRS), bought 25,000 shares at $2.00 ($50K) on 2014-08-11, disclosed to the SEC on 2014-08-12.
Open-market purchase of $50k ATRS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2019-12-26 | $707K | — | Filing → |
| ATRS | BUY | 2016-03-21 | $36K | — | Filing → |